In a significant move to strengthen its fight against mpox (formerly monkeypox), Sierra Leone has received 50,000 more doses of the MVA-BN vaccine, thanks to support from international health partners. This brings the country’s total vaccine stock to over 111,000 doses, following an earlier supply of 61,300 doses received in February.

The newly arrived vaccines will support targeted immunization efforts, focusing on frontline healthcare workers, vulnerable populations, and communities with active outbreaks. Health officials emphasized that the vaccines are vital for curbing transmission, especially in high-risk areas.

The World Health Organization (WHO) is working hand-in-hand with Sierra Leone’s Ministry of Health and Sanitation to oversee vaccine distribution, disease surveillance, contact tracing, and public education campaigns.

Mpox, a viral illness characterized by flu-like symptoms and a rash, remains a public health concern due to its potential for rapid spread. This latest vaccine shipment not only strengthens the country’s preparedness but also represents a renewed commitment to protecting public health and saving lives.

Source: Ayv News